The developments made in clinical embryology over the last decades are enormous. Evolution in biotechnology contributes to the development of new methods and techniques, improving the birth rates of healthy children. Through these developments, embryologists can apply new methods, which can either be applied in most IVF cases or increase the chances of success in so-called "difficult cases". The basic belief of Eugonia’s team is that by constantly keeping up with new developments and also through our own research, we can offer the most effective but also individualized infertility treatment.

Some of the recent developments in clinical embryology include:

• Next Generation Sequencing (NGS)
• Comparative genomic Hybridization (CGH)
• Time lapse
• Physiological Intracytoplasmic Sperm Injection (PICSI)
• Oocyte vitrification
• The "omics" in assisted reproduction
• New culture media
• Assisted hatching
• Transplantation of ovarian tissue
• Oocyte in vitro maturation
• Ovarian tissue cryopreservation
• Stem cells cryopresevation
• Metabolomics